The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial

Related Experiment Videos

Eric J Eichhorn1, Michael R Bristow

  • 1Department of Internal Medicine (Cardiology Division), The University of Texas Southwestern and Dallas VA Medical Centers, Dallas, Texas, USA. Eichhorn@Ryburn.swmed.edu

Current Controlled Trials in Cardiovascular Medicine
|January 25, 2002
PubMed

Insights

Beta-adrenergic blockade significantly benefits patients with mild to moderate heart failure. Further research is needed for advanced heart failure patients and specific populations like black patients.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Previous trials like MERIT-HF and CIBIS II showed mortality benefits of beta-blockers in mild to moderate heart failure.
  • The COPERNICUS trial extended these findings to more advanced heart failure patients.

Purpose of the Study:

  • To review the established benefits of beta-adrenergic blockade in heart failure.
  • To identify patient populations not adequately represented in prior beta-blocker trials for heart failure.

Main Methods:

  • Review of existing clinical trial data (MERIT-HF, CIBIS II, COPERNICUS).
  • Analysis of patient demographics and clinical characteristics in these trials.

Main Results:

  • Beta-adrenergic blockade demonstrates a mortality benefit across a spectrum of heart failure severity.
  • Certain patient groups, including those with decompensated heart failure and black patients, were underrepresented in key trials.

Conclusions:

  • Beta-blocker therapy is a cornerstone in managing heart failure.
  • Future research should investigate the efficacy and safety of beta-blockade in understudied populations and those with severe or asymptomatic left ventricular dysfunction.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...